dalteparin has been researched along with Digestive System Neoplasms in 3 studies
Dalteparin: A low-molecular-weight fragment of heparin, prepared by nitrous acid depolymerization of porcine mucosal heparin. The mean molecular weight is 4000-6000 daltons. It is used therapeutically as an antithrombotic agent. (From Merck Index, 11th ed)
Digestive System Neoplasms: Tumors or cancer of the DIGESTIVE SYSTEM.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Bergqvist, D | 1 |
| Kelecy, MW | 1 |
| Shutt, T | 1 |
| Rostas, J | 1 |
| Martin, RCG | 1 |
| Eguchi, H | 1 |
| Kawamoto, K | 1 |
| Tsujie, M | 1 |
| Yukawa, M | 1 |
| Kubota, M | 1 |
| Asaoka, T | 1 |
| Takeda, Y | 1 |
| Noda, T | 1 |
| Shimizu, J | 1 |
| Nagano, H | 1 |
| Doki, Y | 1 |
| Mori, M | 1 |
1 review available for dalteparin and Digestive System Neoplasms
| Article | Year |
|---|---|
Low-molecular-weight heparin for the prevention of postoperative venous thromboembolism after abdominal surgery: a review.
Topics: Anticoagulants; Colonic Diseases; Digestive System Diseases; Digestive System Neoplasms; Digestive S | 2005 |
1 trial available for dalteparin and Digestive System Neoplasms
| Article | Year |
|---|---|
A Prospective, Multi-Center Phase I Study of Postoperative Enoxaparin Treatment in Patients Undergoing Curative Hepatobiliary-Pancreatic Surgery for Malignancies.
Topics: Adult; Aged; Aged, 80 and over; Anticoagulants; Biliary Tract Neoplasms; Chemoprevention; Digestive | 2020 |
1 other study available for dalteparin and Digestive System Neoplasms
| Article | Year |
|---|---|
Clinical effect of enoxaparin on international normalized ratio following hepato-pancreatico-biliary and gastroesophageal resection.
Topics: Adult; Aged; Aged, 80 and over; Anticoagulants; Digestive System Neoplasms; Digestive System Surgica | 2018 |